设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

2020 年第 8 期 第 15 卷

DNA聚合酶δ催化亚基基因在三阴性乳腺癌组织中的表达及其与预后的关系研究

DNA poly merase chain catalytic subunit gene expression in Triple-negative breast cancer

作者:夏地也·吐尔洪1甫拉提·吾瓦力汉1依日夏提·艾海提2张明帅1蒋威华1

英文作者:Xiadiye Tuerhong1 Fulati Wuwalihan1 Yirixiati Aihaiti2 Zhang Mingshuai1 Jiang Weihua1

单位:1新疆医科大学附属肿瘤医院乳腺外科,乌鲁木齐830011;2西安交通大学2017级硕士研究生710000 

英文单位:1Department of Breast Surgery Tumor Hospital Affiliated to Xinjiang Medical University Urumqi 830011 China; 2 2017 Graduate Student of Xi′an Jiaotong University Xi′an 710000  China

关键词:三阴性乳腺癌;DNA聚合酶δ催化亚基基因

英文关键词:riple-negativebreastcancer;DNApolymerasechaincatalyticsubunitgene

  • 摘要:
  • 目的 观察三阴性乳腺癌组织与对应癌旁组织中DNA聚合酶δ催化亚基基因(POLD1)的表达及其与预后的相关性。方法 采用荧光定量PCR及免疫组织化学的方法 检测110例三阴性乳腺癌患者癌组织标本及其对应的癌旁正常组织标本中POLD1 蛋白的表达情况。分析POLD1蛋白的差异表达与患者临床病理特征及与预后的关系。结果 110例癌组织中POLD1表达阳性81(73.6%),阴性29(26.4%)。癌旁组织中,POLD1表达阳性24(21.8%),阴性86(78.2%)POLD1在癌组织中表达阳性率明显高于癌旁正常组织(χ2=59.195P<0.001)POLD1的表达与组织学分级、TNM分期和淋巴结转移有关(P=0.0020.0100.018),与年龄、肿瘤大小、Ki-67标记指数、p53和表皮生长因子受体表达等无关。采用Kaplan-Meier法分析总生存期和无进展生存期,POLD1高表达组患者的无进展生存期明显短于POLD1低表达组(P=0.038),总生存期与POLD1低表达组比较差异无统计学意义(P>0.05)。Cox回归分析结果 显示,POLD1表达、TNM分期、淋巴结转移是影响三阴性乳腺癌患者无进展生存期的独立危险因素(风险比=0.38095%置信区间:0.1470.985;风险比=4.81695%置信区间:1.85612.496;风险比=2.81095%置信区间:1.4355.506;均P0.05)结论 POLD1蛋白的高表达提示三阴性乳腺癌较差的临床预后。

  • Objective To explore the expression of DNA polymerase δ catalytic subunit gene (POLD1) in triple-negative breast cancer TNBC. Methods The levels of POLD1 protein in 110 TNBC tissue specimens and the para-cancerous tissues were detected by immunohistochemistry. The relation among POLD1 protein, pathological features and prognosis of patients was analyzed. Results In 110 cancer tissues, 81 cases(73.6%) were positive for POLD1 expression and 29 cases(26.4%) were negative. In adjacent tissues, 24 cases(21.8%) were positive for POLD1 expression  and 86 cases(78.2%) were negative. POLD1 expression was inconsistent in cancer tissues and adjacent tissues; it was significantly higher in cancer tissues than in adjacent tissues (χ2=59.195P<0.001). The expression of POLD1 was related to histological grade, TNM stage and lymph node metastasis (P=0.002, 0.010, and 0.018); it was not related to age, tumor size, Ki-67 marker index, p53 and EGFR expression. The Kaplan-Meier method was used to analyze the overall survival and disease-free survival. The disease-free survival of patients with high expression of POLD1 was significantly shorter than that of patients with low expression of POLD1 (P=0.038), but it had no significant effect on overall survival (P>0.05). In addition, Cox proportional hazards model showed that POLD1 expression, lymph node metastasis and TNM staging were independent risk factors of DFS (risk ratio=0.380, 95% confidence interval: 0.147-0.985; hazard ratio=4.816, 95% confidence interval: 1.856-12.496; hazard ratio=2.810, 95% confidence interval: 1.435-5.506; all P0.05). Conclusion The high expression of POLD1 may be related with the poor clinical outcome of TNBC.

copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭
Baidu
map